Logistic analysis for the individual cancer group adjusted for age and sex
| Cancer groups (NORDCAN) | p Value | OR (95% CI) |
| Pancreas | 0.184 | 1.50 (0.83 to 2.72) |
| Brain/CNS | 0.159 | 0.66 (0.38 to 1.16) |
| Cervix uteri | 0.503 | 1.18 (0.73 to 1.94) |
| Leukaemia | 0.233 | 0.73 (0.43 to 1.23) |
| Lip, oral cavity and pharynx | 0.496 | 1.18 (0.73 to 1.92) |
| Corpus uteri | 0.797 | 1.06 (0.69 to 1.62) |
| Rectum and anus | 0.470 | 0.85 (0.55 to 1.31) |
| Melanoma of skin | 0.262 | 0.79 (0.51 to 1.20) |
| Prostate | 0.455 | 1.16 (0.78 to 1.73) |
| Colon | 0.215 | 0.78 (0.53 to 1.15) |
| Bladder, etc | 0.039 | 1.44 (1.02 to 2.05) |
| Lung | 0.720 | 1.06 (0.78 to 1.43) |
| Colorectal | 0.187 | 0.82 (0.61 to 1.10) |
| Breast | 0.031 | 0.80 (0.65 to 0.98) |
| Skin, non-melanoma | 0.020 | 0.82 (0.70 to 0.97) |
| All sites but non-melanoma skin cancer | 0.415 | 0.96 (0.86 to 1.06) |
| Final logistic analysis | ||
| Bladder, etc | 0.040 | 1.44 (1.02 to 2.05) |
| Breast | 0.035 | 0.80 (0.65 to 0.98) |
| Skin, non-melanoma | 0.021 | 0.83 (0.70 to 0.97) |
| Brain/CNS | 0.513 | 1.35 (0.55 to 3.33) |
| Brain/CNS×sex | 0.080 | 0.36 (0.12 to 1.13) |
The last six rows are the final analysis outcome with the interaction variable and the significant cancer groups. CNS, central nervous system.